Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Henault

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|October 19, 2018
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discoveryChaoyang Ye, Daniel J Ho, Marilisa Neri, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2009
Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonistsShilan Liu, Yinhui Liu, Hongmei Wang, et al.
ACS Chemical Biology|May 4, 2022
DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug DiscoveryJingyao Li, Daniel J Ho, Martin Henault, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2010
Synthesis and evaluation of a new series of Neuropeptide S receptor antagonistsJeffrey Y Melamed, Amy E Zartman, Nathan R Kett, et al.
ACS Chemical Biology|April 2, 2024
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening ProfilesJason R Thomas, Claude Shelton, Jason Murphy, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Nature Chemical Biology|March 7, 2020
Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Nature Chemical Biology|December 11, 2019
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|October 19, 2018
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discoveryChaoyang Ye, Daniel J Ho, Marilisa Neri, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2009
Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonistsShilan Liu, Yinhui Liu, Hongmei Wang, et al.
ACS Chemical Biology|May 4, 2022
DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug DiscoveryJingyao Li, Daniel J Ho, Martin Henault, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2010
Synthesis and evaluation of a new series of Neuropeptide S receptor antagonistsJeffrey Y Melamed, Amy E Zartman, Nathan R Kett, et al.
ACS Chemical Biology|April 2, 2024
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening ProfilesJason R Thomas, Claude Shelton, Jason Murphy, et al.
Nature Communications|January 4, 2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistanceMartin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Nature Chemical Biology|March 7, 2020
Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Nature Chemical Biology|December 11, 2019
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNathan T Ross, Felix Lohmann, Seth Carbonneau, et al.
Pageof 2